Trials / Completed
CompletedNCT06945393
ANTIPIGMENTING OR DEPIMENTING EFFICACY UNDER PART OF VISIBLE LIGHT
EVALUATION OF THE EFFICACY OF ANTIPIGMENTING OR DEPIMENTING AGENTS UNDER PART OF VISIBLE LIGHT [400-450NM] EXPOSURES
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- L'Oreal · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The study intends to validate a protocol and define a positive reference to evaluate the efficacy of anti-pigmenting and depigmenting agents under part of visible Light exposures, between 400nm to 450nm. It is carried out on cosmetic products for which the safety has been assured by a toxicologist, with the aim of confirming the efficacy of the products, which will be used by a large number of consumers under normal and reasonably foreseeable use conditions.
Detailed description
The main objective of this study is to assess the efficacy of antipigmenting or depigmenting agents under \[400-450nm\] exposure in healthy volunteers by skin colorimetry (Delta E). The secondary objectives are: * To assess the efficacy of antipigmenting or depigmenting agents under \[400-450nm\] exposure in healthy volunteers by clinical evaluation and additional colorimetry measurements (Delta L\*, a\*, b\* and ITA°) and clinical evaluation. * To assess the local tolerance and safety of the topical formulations under \[400-450nm\] exposure by recording adverse events and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cosmetic topical products | Cosmetic topical products efficacy evaluation |
Timeline
- Start date
- 2021-10-21
- Primary completion
- 2022-05-21
- Completion
- 2022-05-21
- First posted
- 2025-04-25
- Last updated
- 2025-04-25
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT06945393. Inclusion in this directory is not an endorsement.